- Home
- Products
- Customized FluoroAb™
- HAVCR1
- Anti-HAVCR1 MAb (Clone 1)-iFluor® 460 Succinimidyl Ester
Anti-HAVCR1 MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8136)
This product is comprised of an Human Anti-HAVCR1 Antibody (Clone 1) labeled with iFluor® 460 Succinimidyl Ester. iFluor® 460 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- HAVCR1
- Overview
- Human Anti-HAVCR1 Antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 460 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 468/493
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS8136. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-438 | Anti-HAVCR1-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD70 MAb (Clone 4)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9643)
- Anti-TNFRSF8 MAb (Clone 11)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12677)
- Anti-CD79B MAb (Clone 8)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3421)
- Anti-S. aureus ClfA MAb (Clone 2)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9291)
- Anti-CD2 MAb (Clone 11)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4184)
- Clenoliximab-iFluor 594 (CAT#: ADC-FL-692)
- Anti-B. anthracis PA MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9962)
- Anti-CD3E MAb (Clone 14)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1131)
- Anti-DLL3 MAb (Clone 8)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5526)
- Anti-MS4A1 MAb (Clone 8)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14501)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
